ABBV SEC Form 4 filings

Abbvie Inc. Latest Insider Trading Activity

Over the past 1,239 days, 16 insider trades from Abbvie Inc. (ABBV). The most recent SEC Form 4 filing shows a sale by Purdue David Ryan (Abbvie Inc. SVP, Controller) on March 4, 2026 involving 5,230 shares at $233.56 per share. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.

Insider Trading For ABBV Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).

▲ Insider buy ▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
Ticker Filing Date Transaction Date Company Insider Title Transaction Trade Count Shares Avg. Price Total Value Position Size Change SEC Filing
Unexplained: transactions without an ESPP, DRIP, 10b5-1, tax liability, or Explained M/S tag. ABBV 2026-03-06 2026-03-04 Abbvie Inc. Purdue David Ryan SVP, Controller Sell 1 5,230 $233.56 $1,221,518.80 66.34% View Filing
10b5-1: Scheduled Form 4 Transaction ABBV 2026-03-03 2026-03-02 Abbvie Inc. Siatis Perry C EVP, GC AND SECRETARY Sell 3 18,668 $234.39 $4,375,549.33 38.88% View Filing
10b5-1: Scheduled Form 4 Transaction ABBV 2026-02-27 2026-02-25 Abbvie Inc. Siatis Perry C EVP, GC AND SECRETARY Sell 1 22,381 $230.00 $5,147,630.00 36.98% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. ABBV 2025-08-14 2025-08-12 Abbvie Inc. Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER Sell 1 42,370 $198.42 $8,407,055.40 19.29% View Filing
DRIP: Dividend reinvestment ABBV 2025-08-07 2025-08-05 Abbvie Inc. Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER Sell 2 13,295.17 $198.51 $2,639,252.88 9.51% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. ABBV 2025-04-02 2025-03-31 Abbvie Inc. Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER Sell 2 58,832 $210.08 $12,359,504.28 29.65% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. ABBV 2024-12-18 2024-12-16 Abbvie Inc. Buckbee Kevin K SVP, CONTROLLER Sell 1 1,800 $172.24 $310,032.00 20.49% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. ABBV 2024-03-20 2024-03-18 Abbvie Inc. Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER Sell 3 58,949 $178.79 $10,539,508.07 19.50% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. ABBV 2024-02-23 2024-02-21 Abbvie Inc. Saleki-Gerhardt Azita EVP, CHIEF OPERATIONS OFFICER Sell 1 52,870 $173.71 $9,184,047.70 17.81% View Filing
10b5-1: Scheduled Form 4 Transaction ABBV 2023-04-27 2023-04-25 Abbvie Inc. Sorg Elaine K. SVP, US COMMERCIAL OPERATIONS Sell 1 6,130 $165.00 $1,011,450.00 14.79% View Filing

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 3.00 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.